During heart development the second heart field (SHF) provides progenitor cells for most cardiomyocytes and expresses the homeodomain factor Nkx2-5. We now show that feedback repression of Bmp2/Smad1 signaling by Nkx2-5 critically regulates SHF proliferation and outflow tract (OFT) morphology. In the cardiac fields of Nkx2-5 mutants, genes controlling cardiac specification (including Bmp2) and maintenance of the progenitor state were upregulated, leading initially to progenitor overspecification, but subsequently to failed SHF proliferation and OFT truncation. In Smad1 mutants, SHF proliferation and deployment to the OFT were increased, while Smad1 deletion in Nkx2-5 mutants rescued SHF proliferation and OFT development. In Nkx2-5 hypomorphic mice, which recapitulate human congenital heart disease (CHD), OFT anomalies were also rescued by Smad1 deletion. Our findings demonstrate that Nkx2-5 orchestrates the transition between periods of cardiac induction, progenitor proliferation, and OFT morphogenesis via a Smad1-dependent negative feedback loop, which may be a frequent molecular target in CHD.
INTRODUCTION
The logic of molecular pathways underpinning heart development is poorly understood, and little is known about how such pathways are perturbed in congenital heart disease (CHD). Myocytes of the early heart tube derive from at least two distinct cardiac progenitor cell populations. The cardiac crescent and primary heart tube are derived from cells of the first heart field (FHF) that begin differentiation at the crescent stage. The second heart field (SHF) is a population of undifferentiated multipotent cardiac progenitor cells that proliferate and contribute dynamically to heart tube growth at both inflow and outflow poles, providing the majority of myocytes for the right ventricle (RV) and outflow tract (OFT), as well as contributions to the left ventricle (LV) and atria (Buckingham et al., 2005) .
A number of factors have been implicated in the development of SHF progenitors, including transcription factors Tbx1, Islet-1 (Isl1), Foxh1, Mef2c, and Hand2, and fibroblast growth factors Fgf8 and Fgf10 (Buckingham et al., 2005) . These genes are expressed in SHF cells, and most are downregulated upon SHF cell differentiation, suggesting progenitor-specific roles (Kelly, 2005) . The Tbox transcription factor Tbx1 is a positive regulator of SHF proliferation , potentially via direct control of genes for fibroblast growth factors Fgf8 and Fgf10 (Hu et al., 2004; Vitelli et al., 2002; Xu et al., 2004) . Isl1, along with Gata4 and Foxh1, controls expression of Mef2c, a transcription factor essential for specification of both cardiomyocytes and endothelial lineages (Dodou et al., 2004; von Both et al., 2004) .
The homeodomain factor Nkx2-5 sits high in the cardiac regulatory hierarchy and is expressed in cells of both the FHF and SHF (Stanley et al., 2002) . The human gene, NKX2-5, is to date the most commonly mutated single gene in CHD, accounting for 1%-4% of specific malformations, including disruption of the interatrial wall (atrial septal defect; ASD), malpositioning of the outflow vessels (double-outlet right ventricle; DORV), and a complex congenital condition arising from stenosis of the pulmonary artery termed tetralogy of Fallot (Benson et al., 1999; Elliott et al., 2003; McElhinney et al., 2003; Schott et al., 1998) . Studies in mice show that Nkx2-5 is required for specification and spatial definition of chamber myocardium and for formation and maintenance of elements of the conduction system (Habets et al., 2002; Jay et al., 2004; Lyons et al., 1995; Pashmforoush et al., 2004; Tanaka et al., 1999) . However, expression of Nkx2-5 in cardiac progenitor cells suggests uncharacterized roles for this gene at the earliest stages of cardiogenesis.
Here we use microarray to compare the transcriptomes of Nkx2-5 heterozygous and null mutant embryos and identify an important early role for Nkx2-5 as a negative regulator of genes responsible for cardiac induction and the progenitor state. Furthermore, we provide evidence using Nkx2-5 hypomorphic mice that an Nkx2-5/Bmp2/ Smad1 negative feedback pathway is a molecular target in CHD.
RESULTS
To map progenitor cell descendants in Nkx2-5 mutant hearts, we examined expression of region-specific transgenes. The Mlc3f-nlacZ-2E transgene normally marks the LV and right atrium in the looping heart ( Figure 1A ) (Kelly et al., 1997) , and expression in the single ventricle-like chamber of Nkx2-5 null embryos (Figure 1B) suggests that this chamber is a correlate of the normal LV and mainly derived from the FHF. The narrow, short OFT in mutants was negative for the transgene.
To explore the progenitor composition of mutants further, we examined the expression of transgenes Mlc2v-lacZ, Mef2c-lacZ, and Pitx2c-lacZ that mark the OFT and RV, derivatives of the anterior SHF (Dodou et al., 2004; Kelly et al., 2001; Ross et al., 1996; Shiratori et al., 2001) . All transgenes were expressed in the short outflow region of Nkx2-5 mutant hearts ( Figures 1C-1H) , showing that this region contains SHF descendants. The Mlc2v-lacZ transgene additionally marks a population of SHFderived cells at the outflow pole of the LV (Cai et al., 2003; Ross et al., 1996; Verzi et al., 2005) , and expression was evident at the outflow pole of the ventricle-like chamber in Nkx2-5 mutants ( Figures 1C and 1D ). This LV SHF contribution was not highlighted by expression of Mef2c-lacZ ( Figures 1E and 1F ), as this transgene is known to be silenced in LV cells (Verzi et al., 2005) . Pitx2c-lacZ is expressed in descendants of the left anterior SHF that have been exposed to the left/right morphogen nodal (Shiratori et al., 2001) , and reduced expression in the OFT of null embryos (Figures 1G and 1H) confirmed that the SHF contribution to the heart tube was compromised. Explants from the SHF region of both wild-type and mutant embryos (Zaffran et al., 2004) expressed Mlc1v-nlacZ-24 , marking the SHF (Kelly et al., 2001) but not the LV-specific Mlc3f-nlacZ-2E transgene, and this signature was stable after 48 hr of in vitro culture (data not shown). These data show that both the FHF and SHF contribute to Nkx2-5-null hearts-a primitive LV is established relatively normally from FHF progenitors (albeit with some delay), but the grossly truncated OFT and indistinct RV highlight a prominent SHF defect.
Microarray Profiling of Nkx2-5-Null Hearts To identify genes dysregulated in the heart and heart fields of Nkx2-5 mutants, cDNA microarray was performed using cells purified by fluorescence-activated cell sorting (FACS) from embryos carrying an Nkx2-5 gfp knockin allele that expresses enhanced green fluorescent protein (GFP) under Nkx2-5 control (Biben et al., 2000) (Figure 2A E9.5 (21 ps) . Genes with at least a 1.7-fold change in three or more stages were selected (923 of $16 K unique genes). Unsupervised hierarchal clustering (Eisen et al., 1998) correctly ordered all embryonic stages, and known Nkx2-5-dependent genes were identified ( Figure 2B ). Myofilament protein genes were not selected, confirming that cardiomyocyte differentiation is unaffected in mutants (Lyons et al., 1995) .
Nkx2-5 Negatively Regulates Cardiac Progenitor Genes
The most numerous and substantial gene-expression changes were from 15 to 21 ps, with functional annotation suggesting a preterminal state (see Figure S1 legend). We assessed earlier stages and saw upregulation of a cohort of genes from 6 to 21 ps in mutants ( Figure 2B ). Twenty genes expressed at 8-12 ps were prioritized using a < 1/ 100 false-positive cut-off (Tusher et al., 2001) , and their upregulation was confirmed by quantitative (q) RT-PCR ( Figure S1A ) and in situ hybridization (ISH). Region-specific expression was observed for 9 out of 20 upregulated genes by ISH. All nine were expressed in cardiac progenitor cells, i.e., precardiac mesoderm and the early crescent, with all bar one (Tbx5) downregulated in the forming heart tube. Seven genes were previously unrecognized markers for cardiac progenitors. All were expressed, albeit transiently, in the precardiac region and early cardiac crescent, examples being genes for insulin-like growth factor binding protein (Igfbp5), platelet-derived growth factor receptor a (Pdgfra), and transmembrane protein Odz4 ( Figures 3A, 3B , 3E, 3F, and S2A-S2C). Later patterns identified novel subpopulations within the SHF, e.g., at late crescent stages, genes for Igfbp5, Pdgfra, and Odz4, as well as matrix protein tenascin C (Tnc) and homeodomain transcription factor Pbx3 were expressed most strongly in caudal SHF progenitors ( Figures 3A, 3B , 3E, 3F, 3M, 3N, and S2A-S2D). Anteriorly, Tnc was expressed in the lateral reaches of SHF mesoderm (wild-type embryos in Figures 3M-3O ), while Pdgfra was expressed more medially in dorsal mesocardium.
In Nkx2-5-null embryos, most of these progenitor genes failed to undergo downregulation in definitive cardiac structures; e.g., at E8-8.5 Igfbp5 and Pdgfra expression persisted throughout the entire early heart tube ( Figures  3A-3H ). We also examined expression of Pdgfra protein.
In wild-types, expression was seen in the cardiac crescent then strongly in caudal progenitors and dorsal mesocardium ( Figures 3I and 3K ), resembling the mRNA pattern ( Figures 3E-3G ). In null embryos, expression was seen throughout the heart tube ( Figures 3J and 3L ). Expression of Tnc did not persist in the mutant heart tube but was strikingly upregulated in the dorsal mesocardium and dorsal pericardial SHF mesoderm ( Figures  3M-3P ).
Isl1 Is a Pan-Cardiac Progenitor Marker Negatively Regulated by Nkx2-5 We examined expression of SHF marker Isl1, not present on our arrays. In wild-type embryos Isl1 transcripts were abundant in the SHF but undetectable in cardiomyocytes of the crescent and heart tube ( Figures 3Q-3S ), supporting published data (Cai et al., 2003) . However, in Nkx2-5-null embryos, Isl1 expression persisted in cardiomyocytes of the cardiac crescent and heart tube ( Figures 3Q-3T ). By qRT-PCR, Isl1 mRNA was upregulated 4-fold in FACS-purified GFP + cells from Nkx2-5 gfp/gfp embryos at 6-12 ps ( Figure S1A ).
In contrast to Isl1 mRNA, Isl1 protein was expressed in E7.5 wild-type embryos throughout the anterior intraembryonic coelomic walls and proximal head mesenchyme, regions that encompass both the FHF and SHF ( Figure 3U ), as well as in ventral and lateral foregut endoderm. Thus, Isl1 is likely to be a pan-cardiac progenitor marker in mouse. By E8.0, Isl1 expression was lost in differentiating cardiomyocytes of the late crescent/forming heart tube ( Figure 3W ). In Nkx2-5-null embryos, however, Isl1 levels were increased in anterior coelomic walls and foregut endoderm at E7.5, and Isl1 persisted in cardiomyocytes of the late cardiac crescent and heart tube (Figures 3V and 3X) . Expression of Mef2c and Tgfb2, other SHF genes not present on the array, also persisted in the heart tube of Nkx2-5 mutants ( Figures S2E and S2F ).
Quantitative Analysis of Cardiac Progenitor Phenotype in Nkx2-5-Mutant Embryos
We used the novel cardiac progenitor marker Pdgfra to perform a quantitative FACS analysis of the persistent progenitor phenotype seen in Nkx2-5-null hearts. Nkx2-5-null embryos harbored a $2-fold increase in the number of Nkx2-5-GFP + /Pdgfra + progenitor cells from 6 to 20 ps ( Figure S3A ), attributable to the persistent expression of Pdgfra in the mutant heart tube ( Figures 3E-3L ). Importantly, mean Pdgfra expression per cell was not altered in Nkx2-5-null embryos (not shown). Other features of this quantitative analysis were noteworthy. In Nkx2-5 gfp/+ controls, both cranial and caudal Nkx2-5-GFP + SHF subpopulations were characterized by $5-fold lower mean levels of Nkx2-5-GFP compared to differentiating myocytes ( Figure S3B ). Furthermore, mean GFP expression per cell was higher in both Nkx2-5-GFP + and Nkx2-5-GFP + /Pdgfra + cells isolated from mutants compared to heterozygotes (10-20 ps), suggesting that, as for other progenitor genes, Nkx2-5 is a target of negative feedback regulation ( Figures S3B-S3D ).
Nkx2-5 Limits Cardiomyocyte Specification
The data above show that Nkx2-5 is essential for repressing early cardiac progenitor genes. We explored whether this repressive activity served to limit cardiac specification. Assessed by FACS, the number of Nkx2-5-GFP + cells was greater in mutants than in heterozygous controls from 6 to 15 ps ( Figure 4A ). The effect was more pronounced at earlier stages, with $2-fold more Nkx2-5-GFP + cells in mutants at 6-8 ps. ISH using a GFP probe suggested expansion of Nkx2-5 expression specifically in SHF cells, i.e., medial to the cardiac crescent at E7.75 and dorsolateral and anterior to the heart tube at E8.5 ( Figures  4B-4D ).
We confirmed an expansion in the number of Nkx2-5-expressing cells using lacZ staining of Nkx2-5 lacZ/+ heterozygous and Nkx2-5 gfp/lacZ -null embryos, matched for dosage of an Nkx2-5-lacZ knockin allele (Elliott et al., 2006) . In null embryos at E8.0 (5 ps), lacZ was more broadly expressed in mesoderm dorsal to the heart tube at all anterior-posterior levels . This finding was not biased by the negative autoregulatory action of Nkx2-5 that became evident only after 10 ps ( Figure S3B ). We examined lacZ expression at the earliest time of its onset in anterior lateral plate mesoderm at E7.5 ( Figure 4E ). Even at this stage, expression was evident in more cells in null embryos. Expanded expression of early cardiac transcription factor markers, Gata4 and Tbx5, in null embryos at E7.75-8.0 (Figures 4Q-4S) confirmed that there was an expansion of the FHF at early stages in mutants. Tbx5 was upregulated 2-fold in null embryos at E8.0-8.5 by microarray.
Elevated Bmp2 Signaling in Nkx2-5-Null Embryos Nkx2-5 was also ectopically expressed in the ventral neural tube from $E8.75, as detected by ISH for GFP and lacZ staining in respective mutant strains, an effect that increased dramatically with further development ( Figures  4D, 4G , 4N-4P, and S2G). Neural Nkx2-5 expression was not secondary to a preterminal state because it was absent in similarly compromised Tbx20 lacZ/lacZ -null embryos ( Figure S2H ) (Stennard et al., 2005) . This suggested the action of a long-range diffusible morphogen accompanying the increased specification of cardiac progenitors in Nkx2-5-null embryos. We therefore examined the expression of known secreted cardiac-inducing factors. Bmp2 and Fgf10 mRNAs were elevated in mutant FACSpurified Nkx2-5-GFP + cells by microarray and qRT-PCR (3-to 6-fold and 2-to 15-fold, respectively; Figures S1A and S1B). By ISH, Bmp2 mRNA was elevated in mutants in the cardiac crescent (E8.0; Figures 5A-5C) and then at the pericardial/myocardial boundaries at the poles of the heart tube (E8.5; Figure 5D ). Bmp4 and Bmp7 were not upregulated. Bmp signaling through Smad1/5/8 phosphorylation (pSmad1/5/8) was also increased in mutant precardiac mesoderm (E7.75; Figures 5E and 5F), then in the fusing heart tube and SHF (E8.0; Figures 5G-5I ). Elevated phospho-Smad1/5/8 extended to anterior foregut and visceral endoderm of null mutants (Figures 5E-5I) as well as to neural ectoderm from E8.0-9.5 (Figures 5H and 5I). While pSmad was elevated broadly in mutants, Bmp2 upregulation remained confined to its normal pattern of expression, indicating an enhanced paracrine and indeed long-range effect of mesoderm-expressed Bmp2 on endoderm and ectoderm. Expression of genes encoding Bmp inhibitors, Cer1, Dan, and noggin was not altered in Nkx2-5 mutants (not shown). Fgf10 was also upregulated and more broadly expressed in the cardiac crescent region of Nkx2-5 mutants at E7.5, as seen by ISH ( Figure 5J ), and expression persisted throughout the mutant heart tube (E8.5-9.5; Figures 5K and 5L) . Fgf8 expression was not elevated ( Figure S1B ). The Mlc1v-nlacZ-24 transgene traps an Fgf10 enhancer expressed in the SHF and in its anterior derivatives, the OFT/RV (Kelly et al., 2001) . In mutants, increased b-galactosidase activity was evident in cardiomyocytes of the crescent, then whole heart tube at E9.5 ( Figures 5M-5P ), similar to findings for Fgf10 mRNA. Double immunostaining of sections from Mlc1v-nlacZ-24 embryos at the late crescent stage showed some overlap between myosin expression, marking the zone of differentiation in FHF and SHF cells, and lacZ expression, which marks the SHF. In Nkx2-5 mutants, there was greater encroachment of b-galactosidase protein expression into the FHF in the cranial region (E7.75; Figures 5Q and 5R) , indicating a very early effect on Fgf10.
The homeodomain repressor Hhex is expressed in anterior visceral and foregut endoderm and, when overexpressed in frog blastomeres, can induce Nkx2-5 expression in adjacent mesoderm (Foley and Mercola, 2005) . Hhex was upregulated in Nkx2-5 mutants in anterior endoderm underlying the cardiac crescent ( Figures 5S-5V ) as well as in endothelial progenitors within head mesenchyme, again suggestive of the action of a long-range morphogen. Hhex may be induced in mutants by upregulated Bmp2 via its Smad-responsive enhancer (Zhang et al., 2002) . Expression of Dkk1, encoding a canonical Wnt inhibitor that can also induce Hhex (Foley and Mercola, 2005) , was unaffected. Cardiogenesis can be stimulated in frog embryos by the noncanonical Wnt pathway ligand, Wnt11 (Pandur et al., 2002) . However, Wnt11 was downregulated in mutants ( Figures 5W, 5X , 6O, and 6P).
Nkx2-5 Is Required for SHF Proliferation through Suppression of Bmp2/Smad1 Signaling Impaired proliferation or deployment of SHF cells may underpin the dramatically narrowed and shortened OFT seen in Nkx2-5 mutants. We examined proliferation of SHF progenitors in mutants, scoring for phosphohistone H3. As reported (Tanaka et al., 1999 (Tanaka et al., , 2001 , foregut endoderm proliferation showed a reduction by 44% in mutants (p = 0.011; Figure 6A ), but cardiomyocytes were unaffected. However, we also found that proliferation was strikingly reduced in dorsal pericardial SHF cells (80% reduced, p < 0.0001) in the absence of effects on cell death (not shown). The Bmp inhibitor noggin stimulates cell proliferation in chick SHF explants (Waldo et al., 2001 ). To examine whether Bmp/Smad signaling represses SHF progenitor proliferation in vivo, we deleted loxP-flanked (floxed; fl) Smad1 alleles (Tremblay et al., 2001 ) specifically in anterior mesoderm, using Mesp1-Cre (Saga et al., 1999) . Strikingly, Mesp
Cre/+ /Smad1 fl/fl embryos showed a 2.3-fold increase in proliferation of SHF cells at E8.5 (p < 0.0005; Figure 6B ) but no change in myocyte proliferation. Proliferation was unaffected in foregut endoderm ( Figure 6B ) that expressed Smad1 ( Figure 5H ) but not Mesp1-Cre (Saga et al., 1999) , and we conclude, therefore, that the observed effects are not secondary to an altered state of endoderm. Consistent with our hypothesis that SHF proliferation is a driver of OFT/RV morphogenesis, the length (5/7 embryos) or length plus width (2/7 embryos) of the OFT/RV in Mesp Cre/+ /Smad1 fl/fl hearts was increased at E9.5 (Figures 6D-6F) .
We also assessed whether there was a cell autonomous migration defect in Nkx2-5-null SHF cells by examining their ability to be deployed to the OFT/RV in a competitive situation with wild-type cells in embryo chimeras ( Figure S4 ). However, we found no evidence for a defect in this assay.
Genetic Rescue of OFT Formation in Nkx2-5-Null Embryos
To test genetically whether defective OFT development in Nkx2-5 mutants was due to increased Bmp-Smad signaling, we crossed Nkx2-5 and Smad1 mutant mice. Deletion of one or two Smad1 alleles in Nkx2-5 gfp/gfp embryos produced a progressive increase in SHF proliferation (1.5-fold, p = 0.059 and 3.1-fold, p = 0.004, respectively, compared to Nkx2-5 nulls; Figure 6C ). SHF proliferation in Nkx2-5/Smad1-double-null embryos was only 23% less than in wild-type embryos, indicating that most of the antiproliferative effect of increased Bmp2 was mediated by Smad1. We found no precocious differentiation in the SHF in Nkx2-5 mutants, indicating that the negative effects of increased Bmp2-Smad1 signaling on SHF proliferation were independent of any prodifferentiative activity of Bmps ( Figure S5 ). Bmp2 remained upregulated at the pericardial/myocardial boundary in Nkx2-5 gfp/gfp / Smad1 À/À embryos ( Figures 6G-6J ), indicating that Nkx2-5-mediated repression of Bmp2 was independent of Smad1. However, the ectopic expression of Nkx2-5-GFP within the head mesenchyme, dorsal foregut, and neural tube of Nkx2-5 mutants was eliminated by Smad1 deletion (Figures 6K-6N) . Therefore, upregulated Bmp2-Smad1 signaling can account for elevated cardiac specification and reduced SHF proliferation in Nkx2-5 mutants.
We therefore favor the hypothesis that Nkx2-5 acts indirectly to repress progenitor cell specification and proliferation.
In the forming heart, Wnt11 expression marks the inflow and outflow poles ( Figures 6O, O 0 , and O 00 ), which are derivatives of the SHF. At E8.5, Smad1
À/À heart tubes were truncated and partially bifid (Figures 6Q and Q 00 ) (M.J.S., M.B.F., and R.P.H., unpublished data). Smad1 À/À hearts initially expressed Wnt11 throughout most of the myocardium, suggesting that the primary heart tube in this mutant context is formed predominantly from SHF cells, a possible result of retarded specification of FHF cells and/or increased SHF proliferation. As shown above, Nkx2-5 gfp/gfp hearts have a highly compromised SHF-derived component and accordingly showed downregulated Wnt11 (Figures 6P Figures 6S-6V ). Thus, Nkx2-5 represses cardiac progenitor genes through multiple targets.
The Nkx2-5/Bmp2/Smad1 Negative Feedback Loop Is a Molecular Target in CHD We found that our previously established Nkx2-5-IREScre knockin allele (Stanley et al., 2002) were hypomorphic and died postnatally, showing a spectrum of cardiac malformations overlapping the more severe defects seen in humans with NKX2-5 mutations ( Figures 7A-7D ). At mid-to-late gestation (E14.5 or E17.5; n = 29), all hypomorphic hearts showed a ventricular septal defect (VSD), malrotation of the OFT vessels, and either DORV or a related condition in which the aorta is positioned above a VSD (overriding aorta OA; Figures 7A-7D and 7Q). Similar malformations were seen at birth. Other frequent abnormalities included interruption of the interatrial septum primum (primum ASD), immature or absent mitral and tricuspid valves, and thin-walled ventricles (Figures 7D and 7Q-7T and Table S2 ). Outflow vessel defects seen in Nkx2-5 hypomorphs at midgestation were predated by OFT defects in earlier embryos; e.g., the OFT was shorter and thinner and the RV bulge less prominent at E8.5-9.5 compared to Nkx2-5 +/IRES-cre controls (Figures 7E-7H ). These OFT defects may be a less severe manifestation of those seen in Nkx2-5 nulls. Indeed, at late head-fold stages (E7.75), Bmp2 and Isl1 expressions were elevated in hypomorphs ( Figures 7I-7K) , as was Nkx2-5-IRES-cre expression measured by qRT-PCR (1.4-fold increase, p = 0.041), the latter indicative of cardiac progenitor overspecification. We also examined proliferation in hypomorphs at E8.5 and found a decrease in the SHF of 51% but no effect on OFT/RV cardiomyocytes ( Figure 7L ; p = 0.024). Following logic established for null embryos, we asked whether the OFT/RV defects seen in Nkx2-5 hypomorphs could be rescued by Smad1 deletion. Deletion of one Smad1 allele in the germline, or a floxed Smad1 allele via expression of Cre from the Nkx2-5-IRES-cre allele, was sufficient to increase the size of the OFT and RV swelling at E9.5 ( Figures 7M and 7N ). In conditionally deleted Nkx2-5 gfp/IRES-cre /Smad1 fl/+ embryos at E14.5, malrotation and rightward displacement of the OFT vessels were largely corrected, and in 11 of 13 cases, the aorta was correctly oriented leftwards and connected directly to the LV (p = 0.00024; Table S2 and Figures 7O-7X ). VSD and mitral valve dysmorphogenesis was also less severe in Nkx2-5 gfp/IRES-cre hypomorphs with conditionally deleted Smad1 (p = 0.0022 and p = 0.018, respectively; Table S2 and Figures 7Q-7X ). RV size was also improved in some embryos ( Figures 7O-7X) , and in most, maturation of the tricuspid valve was enhanced and an intact atrial septum was restored, although in isolation these results did not reach significance (p = 0.053 and p = 0.14, respectively; Table S2 ). Normal OFT vessel connections, intact atrial septa, and improved RV size, AV valve morphology and VSD severity, were also observed in two Nkx2-5 gfp/IRES-cre /Smad1 fl/fl embryos recovered at E14.5.
DISCUSSION
In Nkx2-5 mutants, the upregulation of progenitor signature genes in the SHF and the abnormal persistence of expression in differentiating myocytes indicate a major early role for Nkx2-5 in modulating expression of genes associated with cardiac induction and progenitor cell status. The majority of the progenitor genes affected by loss of Nkx2-5 were expressed in both the FHF and SHF. Expression in the FHF was extremely transient, reflecting the early differentiation of these progenitors in the cardiac crescent. For example, Isl1, previously thought to be SHF specific, was expressed throughout the intraembryonic coelomic lining at E7.5, which contains components of both progenitor fields and is therefore likely to be a pan-cardiac progenitor cell marker in mice. Transient FHF Isl1 expression may account for the dearth of marked FHF descendents in a Cre-fate map (Cai et al., 2003) . The expression patterns of progenitor markers define new subpopulations and/or their behavioral states. In the SHF, Tnc, Pdgfra, and Igfbp5 were expressed most highly in caudal cells, while anteriorly, expression of Pdgfra was restricted to its medial portion (dorsal mesocardium) and that of Tnc to the most lateral regions. In contrast to skeletal muscle development, where proliferation ceases as differentiation begins and for which there are relatively clear molecular signatures for progenitors (Pax3/7), myoblasts (MyoD, Myf5) and myocytes (myogenin and contractile proteins), cardiac cells continue to proliferate during differentiation. It is possible that some of the identified markers will reflect analogous progressions in the cardiac lineage, although the distinction between progenitor, blast, and differentiated states seem less distinct in cardiac muscle.
An Nkx2-5/Bmp2/Smad1 Negative Regulatory Circuit Limits Cardiac Specification We attribute both overspecification and proliferative failure of cardiac progenitor cells in Nkx2-5 mutants to an overactive Bmp2/Smad1 pathway. Several observations suggested involvement of a long-range diffusible morphogen in the spectrum of defects seen in Nkx2-5 mutants, including upregulation of Bmp2 in the cardiac fields and increased levels of phospho-Smad1/5/8 in and beyond the fields. Bmp2-related factors are cardiac-inducing molecules in vertebrates and invertebrates, with Nkx2-5 and its Drosophila homolog tinman being direct transcriptional targets of Bmp-Smads (Liberatore et al., 2002; Lien et al., 2002) . Therefore, an early and possibly direct function for Nkx2-5 in the cardiac developmental program is to Quackenbush-Swiss/25% C57BL/6) and for littermate embryos from Nkx2-5 +/gfp X Smad1 +/À crosses (C, E8.5, 10-12 ps, 50% Quackenbush-Swiss/ 50% C57BL/6). Shown is the mean percentage of phosphohistone H3 + (pHH3) cells ± standard deviation (SD), n = 3 for each genotype. (Waldo et al., 2001) , and, as shown here genetically, Smad1 is a critical negative regulator of SHF proliferation in vivo. In contrast to the FHF, SHF cells undergo an extended period of mitotic expansion lasting several days prior to, and overlapping with, their deployment to the OFT/RV and differentiation. The decreased proliferation of the SHF in Nkx2-5 mutants likely accounts for the progressive normalization in numbers of Nkx2-5-GFP + cells following their initial overspecification. A model for the feedback loop involving Nkx2-5, Bmp2, and Smad1 and its role in cardiac specification, progenitor gene expression, and proliferation is presented in Figure S6 . In the context of developmental time, the repressive action of Nkx2-5 on Bmp2/Smad1 orchestrates the transition between a period of cardiac induction and one of progenitor proliferation, a negative feedback that is likely to be a fundamental property of cardiac developmental circuitry in all vertebrates. Given that Nkx2-5 levels increase from the progenitor to the differentiated state, the negative feedback pathway may be an example of how the number of progenitor cells in a field is controlled by the degree of differentiation-a paradigm that could apply to adult stem cells and organ regeneration. In this paradigm, Nkx2-5 acts as both the sensor of differentiation and as the arbiter of repression. Because the negative feedback loop balances the number of cardiac progenitors through opposing effects on induction and proliferation, it is self regulating and thereby shows features of robustness, an essential component of developmental systems.
Coexpression of genes defining cardiac progenitor cells, including Isl1, with cardiomyogenic genes in Nkx2-5-null heart tubes demonstrates that Nkx2-5 also plays a critical role as a molecular switch in ensuring spatial and temporal discrimination of the progenitor and differentiating states. However, persistent expression of Isl1 (and presumably other progenitor genes) in the forming heart tube of Nkx2-5 mutants was not rescued by Smad1 deletion, suggesting that Nkx2-5-dependent negative feedback targets multiple sets of genes with distinct functional consequences for heart development.
A Cardiac Progenitor Cell Defect May Underlie NKX2-5-Related CHD The decrease in SHF proliferation in Nkx2-5-null embryos has potential ramifications for our understanding of human NKX2-5-related CHD. We describe a hypomorphic Nkx2-5 model in which animals survived until birth with a spectrum of cardiac anomalies overlapping the more severe malformations seen in some humans with NKX2-5 mutations. Of note is the high penetrance of OFT defects accompanied by large VSD in this model. These are not seen in heterozygous Nkx2-5-null mice (Biben et al., 2000) and are sporadic findings in human patients (McElhinney et al., 2003) , yet are fully penetrant in a heterozygous dominant-negative model of Nkx2-5 deficiency (Elliott et al., 2006) . These findings highlight the fine balance between the effective activity of Nkx2-5 and CHD outcome. In humans, the subtle effects of modifier genes on NKX2-5 levels may explain, in some cases, the variable phenotypes seen in patients with NKX2-5 mutations.
Our data provide support for correlative evidence that SHF proliferation is a critical determinant of SHF deployment and the size and morphology of the OFT/RV. In chick embryos, physical ablation of either the SHF or neural crest, which supports SHF development, leads to a severely decreased contribution of cells to the OFT (Ward et al., 2005; Yelbuz et al., 2002) . This produces abnormal looping and rightward displacement of the OFT, manifesting later as an OA (Ward et al., 2005; Yelbuz et al., 2002) . Nkx2-5 hypomorphs showed diminished SHF proliferation, and OFT size and morphology were compromised as early as E8.5, leading to abnormal displacement of outflow vessels to the right, OA, and, in more severe cases, DORV. These OFT/RV malformations were partially rescued by deletion of one or both Smad1 alleles. However, not all cardiac defects were rescued in Nkx2-5 hypomorphs by Smad1 deletion. In particular, small VSDs and ventricular chamber defects persisted. These are likely caused by a reduction in chamber differentiation, in which Nkx2-5 is known to have a direct role (Pashmforoush et al., 2004) .
OFT defects are among the most severe cardiac congenital malformations and often require surgical intervention in the first year of life. Our study suggests that SHF genes and those involved in the Nkx2-5/Bmp2/Smad1 negative feedback loop will be molecular targets and modifiers in CHD. The discovery of this pathway that balances cardiac progenitor specification and proliferation now provides a basis for further mechanistic investigations in this pathological context, as well as in that of the deployment of stem cells that underlies the formation of the heart and, eventually, also its repair.
EXPERIMENTAL PROCEDURES

Microarray
Amplified RNA from FACS-sorted Nkx2-5 gfp/+ and Nkx2-5 gfp/gfp cells was labeled with Cy3 or Cy5 and hybridized to cDNA arrays. For the full details (MIAME-compliant) of the clone sets used, array printing, sample preparation, labelling, and hybridization, see ArrayExpress database, accession numbers E-MEXP-533 and -534.
Gene/Protein Expression
Controls used in all experiments were somite-matched littermates. ISH was as described (Biben and Harvey, 1997) . Probes are described in Table S1 . For whole-mount immunohistochemistry, PFA-fixed embryos were treated with acetone for 7 min at À20 C, then blocked for 1 hr in 3% skim milk. For Isl1 and pSmad1, embryos were heated at 95 C for 8 min in unmasking solution (Vector Laboratories) prior to acetone fixation. Antibodies used were against Pdgfra (APA5, PharMingen), TER-119 (PharMingen), Isl1 (supernatant 39.4D5, raised against chick Isl1 C terminus, developed by Thomas Jessell, and obtained from the Developmental Studies Hybridoma Bank under the auspices of the NICHD and maintained by the University of Iowa; and goat anti-Isl1, raised against full-length human Isl1, GT15051, Neuromics), phospho-Smad1/5/8 (9511S, Cell Signaling), b-galactosidase (gift from JF Nicolas, Pasteur Institute), sarcomeric myosin heavy chain (MF20, Developmental Studies Hybridoma Bank), and phosphohistone H3 (06-570, Upstate). Quantitative RT-PCR was as described (Stennard et al., 2005) (primers available on request). For statistical methods, see figure legends.
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